Findings from the 2025 IDF Diabetes Atlas with Felix Teufel, Teplizumab & Type 1 Diabetes Therapies with Chantal Mathieu, and more!

About this episode

The episode discusses findings from the 2025 IDF Diabetes Atlas and new therapies for Type 1 diabetes.

Welcome to the latest episode (March 2026) of Diabetes Care "On Air"—a new and different way to bring the research published in Diabetes Care to life. Join co-hosts Alice Cheng, MD, FRCPC, and Michael Rickels, MD, MS, as they discuss the latest and greatest content in the March 2026 issue of Diabetes Care and beyond. 5:45 Alice welcomes Felix Teufel , MD and PhD candidate in global health and development at Emory University's Rollins School of Public Health. He is corresponding author on the article, "Global, Regional, and National Estimates of Undiagnosed Diabetes in Adults: Findings From the 2025 IDF Diabetes Atlas," available for free at doi.org/10.2337/dc25-2583 . 18:25 Mike speaks with Chantal Mathieu , MD, PhD, professor of medicine at the Katholieke Universiteit Leuven in Belgium and chair of endocrinology at the University Hospital Gasthuisberg Leuven. She is corresponding author on the article "Toward Disease-Modifying Therapies in Type 1 Diabetes: Focus on Teplizumab," available for free at doi.org/10.2337/dci25-0066 . 45:55 In this month's "Diabetes Care Rapid Exchange" segment, Alice and Mike wrap up the episode by reviewing several interesting articles in the March…

People in this episode

Hosts: Alice Cheng, Michael Rickels

Guests: Felix Teufel, Chantal Mathieu

Topics covered

• Diabetes research
• Type 1 diabetes therapies
• Global health
• Undiagnosed diabetes
• Gestational diabetes

Keywords

• Diabetes Atlas
• Type 1 diabetes
• Teplizumab
• gestational diabetes
• global health

Mentioned in this episode

Organizations: Emory University, Katholieke Universiteit Leuven, University Hospital Gasthuisberg Leuven

Books & works: Global, Regional, and National Estimates of Undiagnosed Diabetes in Adults: Findings From the 2025 IDF Diabetes Atlas, Toward Disease-Modifying Therapies in Type 1 Diabetes: Focus on Teplizumab, Going From Stage 2 to Stage 3 Type 1 Diabetes—Does Not Matter How You Got Here, The Effect of Midpregnancy Screening for Gestational Diabetes Mellitus on Pregnancy Outcomes

More episodes of Diabetes Care "On Air"

• Lutz Heinemann on the challenges and opportunities of individualizing diabetes technology, Kathleen Dungan on hyperglycemia during acute pancreatitis and the progression to early-onset diabetes, plus a classic edition of "Rapid Exchange." · June 2, 2026 · 58 min
• Naveed Sattar on early, large-scale weight loss & the future of type 2 diabetes care, Laurent Azoulay on GLP-1s & the risk for optic neuropathy, plus a classic edition of "Rapid Exchange." · May 4, 2026 · 50 min
• Anna Kahkoska & Medha Munshi on improving care for T1D in older adulthood, Jennifer Sherr on the persistent burden of severe hypoglycemia in people with T1D despite technology use, plus a classic edition of "Rapid Exchange." · April 2, 2026 · 50 min
• Untold Histories of Diabetes with Vanessa Heggie, Differential Longitudinal Effects of Glucose-Lowering Medications on Glucagon and C-peptide Responses in the Glycemia Reduction Approaches in Diabetes with Steven Kahn, and more! · February 5, 2026 · 45 min
• "How to Fix a Broken Healthcare System" with Seth Berkowitz, Marshall Chin, and Mariana Socal, a classic Rapid Exchange, and more! · January 6, 2026 · 49 min
• Diana Sherifali & Megan Racey on type 2 diabetes remission, Vivian Fonseca on inadequately controlled t2d and hypercortisolism, and more! · December 5, 2025 · 56 min